Sex Disparity in Patients with Gastric Cancer: A Systematic Review and Meta-Analysis
Journal of Oncology · 02.11.2022 · 2022 · 1-16
DOI: 10.1155/2022/1269435 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Oncology, erschienen am 02.11.2022. Verfasst von Xiaoyi Luan und 6 weiteren Autor:innen. Beteiligte Einrichtung: National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical Col…. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Basic Research Program of China.
Abstract (Originalsprache)
Objective
This systematic review and meta-analysis aimed to ascertain whether sex-based differences influence clinicopathological characteristics and survival outcomes of gastric cancer patients.
Background
Gastric cancer in females has received less attention than in males. Clinicopathological features and survival outcomes of females with gastric cancer have been reported in several studies with controversial results.
Methods
We systematically reviewed clinical studies from PubMed, Cochrane Library, Embase, and Web of Science published up to June 2022. The effect sizes of the included studies were estimated using odds ratios (ORs). Heterogeneity was investigated using the χ2 and I2 tests, while sensitivity analyses were performed to identify the source of substantial heterogeneity. All data used in this study were obtained from previously published studies obviating the need for ethical approval and patient consent.
Results
Seventy-six studies with 775,003 gastric cancer patients were included in the meta-analysis. Gastric cancer patients were less likely to be females ( P < 0.00001). Female patients were younger in age ( P < 0.00001) and showed a higher percentage of distal ( P < 0.00001), non-cardia ( P < 0.00001), undifferentiated ( P < 0.00001), diffuse ( P < 0.00001), and signet-ring cell carcinoma ( P < 0.00001). Female patients showed better prognosis in both 3-year ( P = 0.0003) and 5-year overall survival (OS) ( P < 0.00001), especially White patients. However, females were associated with lower 5-year OS relative to males in the younger patients ( P = 0.0001).
Conclusions
In conclusion, gender differences were observed in clinicopathological characteristics and survival outcomes of gastric cancer. Different management of therapy will become necessary for different genders.
Autor:innen und Institutionen
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 Panjiayuan Nanli, Beijing 100021, China.
ORCID-Profile: Yingtai Chen
Förderung
- National Basic Research Program of China
Zitieren
APA
Luan, X., Niu, P., Wang, W., Zhao, L., Zhang, X., Zhao, D., & Chen, Y. (2022). Sex Disparity in Patients with Gastric Cancer: A Systematic Review and Meta-Analysis. Journal of Oncology, 2022, 1-16. https://doi.org/10.1155/2022/1269435
Vancouver
Luan X, Niu P, Wang W, Zhao L, Zhang X, Zhao D, et al. Sex Disparity in Patients with Gastric Cancer: A Systematic Review and Meta-Analysis. Journal of Oncology. 2022;2022:1-16. doi:10.1155/2022/1269435
BibTeX
@article{Luan2022,
author = {Luan, Xiaoyi and Niu, Penghui and Wang, Wanqing and Zhao, Lulu and Zhang, Xiaojie and Zhao, Dongbing and Chen, Yingtai},
title = {Sex Disparity in Patients with Gastric Cancer: A Systematic Review and Meta-Analysis},
journal = {Journal of Oncology},
year = {2022},
volume = {2022},
pages = {1--16},
doi = {10.1155/2022/1269435}
}
EUVIMED